Bill > S1097

This bill establishes an Interagency Task Force on Patents between the United States Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) to improve information sharing and coordination specifically related to patents for human drugs and biological products. The task force will facilitate routine communication and information exchange, including sharing details about application review processes, patent approvals, new technologies, and scientific developments. Key provisions include creating a formal mechanism for USPTO patent examiners to request and receive relevant information from the FDA, such as drug approval updates and product application details, while maintaining strict confidentiality protocols. The bill requires the USPTO Director to submit a report to Congressional judiciary committees within four years, detailing the frequency and usefulness of information sharing, and recommending potential improvements to the task force's operations. The task force's membership will include employees from both agencies with appropriate expertise, and they will develop a memorandum of understanding to guide their collaborative efforts. Importantly, the bill emphasizes that this coordination is meant to enhance patent examination processes without interfering with each agency's existing ministerial functions or changing patent litigation dynamics.

Justice

https://www.congress.gov/bill/119th-congress/senate-bill/1097/all-info